First fully-automated bladder cancer test launched:
This article was originally published in Clinica
Diagnostic Products is launching a fully automated version of Matritech's NMP22 urine test for bladder cancer, which is claimed to be the world's first such test. The automated version, which is designed to be performed on the firm's IMMULITE fully automated analyser, is less labour-intensive and could provide urologists with patient results in around one day, said the Los Angeles, California firm. The test will be available initially outside the US, excluding Japan, and in the US following FDA PMA approval.
You may also be interested in...
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.